• Gharaibeh, Y., Lee, J., Zimin, V., Chaitanya, K., Dallan, L., Pereira, G. T. R., Vergara-Martel, A . . . Wilson, D. (2023). Prediction of Stent Under-Expansion in ...

Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed ...

To facilitate quantitative evaluation of deployed devices, a novel algorithm is presented that generates intuitive two-dimensional representations of wall apposition from either high-resolution ...

Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to ...

Abbott begins new Intravascular Lithotripsy trial to improve outcomes in patients with coronary artery disease: Abbott Park, Illinois Wednesday, March 26, 2025, 15:00 Hrs [IST] Ab ...

Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) ...

Abbott's Coronary IVL System wins FDA IDE nod, offering a potential new treatment for arterial calcium blockages.

Manipal Hospital Old Airport Road, Bengaluru, has appointed Dr. Keshava R as the Head of the Cardiology Department. With over ...

In this study, we aimed to investigate the intravascular characteristics of thick-strut BP-BES and ultrathin ... quantitative coronary angiography; OCT, optical coherence tomography; CSA, cross ...

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, March 21, 2025 (GLOBE NEWSWIRE) -- Conavi ...